Research projects

  • Therapeutic nuclear medicine: “Theranostic radiopharmaceuticals for metastatic cancer” -focusing on targeted alpha therapy (Co-lead, South-Eastern Norway Regional Health Authority Grant), Phase 0 study of a 212Pb-PSMA radiopharmaceutical therapy, Dose-effects for a novel 177-Lu based treatment of non-Hodgkin lymphoma (South-Eastern Norway Regional Health Authority Research Grant), SIMPLERAD (Co-lead WP4, funded by the European Union), Biodistribution and dosimetry in a phase 1 trial of 224-Ra-CaCO3 particles (funded by sponsor), Simulation tools and quantitative 90-Y PET/CT for Selective Internal Radiation Therapy (South-Eastern Norway Regional Health Authority Innovation Grant), Dosimetry-based treatment planning of 131-I therapy.
  • Other studies: “FLUCIPET” –clinical trial investigating Fluciclovine PET for multiple myeloma patients (South-Eastern Norway Regional Health Authority Research Grant), Quantitative PET parameters as predictors for patient outcome (part of different lymphoma trials), radiomics investigations, and various technical projects related to image reconstruction and analyses.
 
Scroll to top